Author:
Chew Sin-Chi,Singh Onkar,Chen Xiangai,Ramasamy Rathi Devi,Kulkarni Tejal,Lee Edmund J. D.,Tan Eng-Huat,Lim Wan-Teck,Chowbay Balram
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Oshiro C, Marsh S, McLeod H et al (2009) Taxane pathway. Pharmacogenet Genomics 19:979–983
2. Wang D, Guo Y, Wrighton S et al (2010) Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs. Pharmacogenomics J. doi: 10.1038/tpj.2010.28
3. Hamada A, Sissung T, Price DK et al (2008) Effect of SLCO1B3 haplotype on testosterone transport and clinical outcome in caucasian patients with androgen-independent prostatic cancer. Clin Cancer Res 14:3312–3318
4. Imai Y, Nakane M, Kage K et al (2002) C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141 K protein and low-level drug resistance. Mol Cancer Ther 1:611–616
5. Letschert K, Keppler D, König J et al (2004) Mutations in the SLCO1B3 gene affecting the substrate specificity of the hepatocellular uptake transporter OATP1B3 (OATP8). Pharmacogenetics 14:441–452
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献